{"id":849,"date":"2020-06-20T13:20:42","date_gmt":"2020-06-20T13:20:42","guid":{"rendered":"http:\/\/bxta-staging.website\/?page_id=849"},"modified":"2020-06-20T13:30:20","modified_gmt":"2020-06-20T13:30:20","slug":"ascende-rt-study","status":"publish","type":"page","link":"https:\/\/bxta.com\/es\/patient-information\/ascende-rt-study\/","title":{"rendered":"ASCENDE-RT Study"},"content":{"rendered":"
\n

The ASCENDE-RT Study<\/h3><\/div><\/div>\n\n\n\n

Intermediate and high-risk prostate cancer patients have double the survival chance with brachytherapy seeds<\/p>\n\n\n\n

\n
<\/div>
Read Study<\/a><\/a><\/div><\/div><\/div>\n\n\n\n
<\/div>
Protocol<\/a><\/a><\/div><\/div><\/div>\n\n\n\n
<\/div>
ASCENDE-RT data sheet Protocol<\/a><\/a><\/div><\/div><\/div>\n\n\n\n
<\/div>
Comment by Sree Rodda<\/a><\/div><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n

BXTAccelyon Limited, the UK-based brachytherapy company supplying seeds, loaded needle assemblies and associated accessories and equipment to hospitals and clinics worldwide has called for an early review of the availability of seed brachytherapy for patients with intermediate and high-risk prostate cancer.<\/p>\n\n\n\n

Low Dose Rate (LDR) Brachytherapy is a form of radiation therapy that involves placing tiny radioactive \u201cseeds\u201d directly into the prostate. The ASCENDE-RT study from Canada, is a randomized trial comparing the use of dose-escalated external beam radiation therapy (DE-EBRT) and low-dose-rate-brachytherapy (LDR-B) in men with intermediate- and high-risk prostate cancer. In summary, the trial demonstrated a 50% decrease in biochemical relapse with the use of LDR-B in conjunction with hormones and whole pelvis radiotherapy when compared to using DE-EBRT with the same treatments in patients randomly assigned to the two forms of treatment.<\/p>\n\n\n\n

In the UK and Ireland, around 45,000 new prostate cancer cases are diagnosed annually and two-thirds of these patients have early stage disease which is suitable for LDR brachytherapy treatment. Currently, over 1,500 patients receive brachytherapy seed treatment annually at 36 centres in the UK & Ireland. In Australia and New Zealand around 23,000 new prostate cancer cases are diagnosed annually and over two-thirds of these patients have early stage disease which is suitable for LDR brachytherapy treatment.<\/p>\n\n\n\n

Saheed Rashid, Director General de BXTAccelyon, a\u00f1ade: \u00abEste tipo de informaci\u00f3n puede ayudar a los sanitarios cl\u00ednicos y asesores de los servicios de salud a determinar cu\u00e1l es el mejor tratamiento para los pacientes de c\u00e1ncer de pr\u00f3stata. El estudio es extremadamente valioso para resaltar la necesidad de un cambio en la pr\u00e1ctica cl\u00ednica de cara a que los hombres con este tipo de enfermedad accedan a un tratamiento que les de el cincuenta por ciento m\u00e1s de oportunidades de estar libres de la enfermedad a largo plazo. Junto a la adecuaci\u00f3n y los beneficios en t\u00e9rminos de ahorro de costes de la braquiterapia de semillas como tratamiento opcional y la \u00abliberaci\u00f3n\u00bb de un tiempo valioso en los dispositivos que utilizamos para dar la radioterapia, este estudio, adem\u00e1s de ser realmente importante para los pacientes de c\u00e1ncer de pr\u00f3stata, tambi\u00e9n lo es para tratar a otros pacientes con otros tipos de c\u00e1ncer\u00bb.<\/p>\n\n\n\n

Para m\u00e1s informaci\u00f3n, p\u00f3ngase en contacto con:<\/p>\n<\/div><\/div><\/div>\n\n\n\n

\n

Saheed Rashid<\/strong> – Director General<\/em><\/p>\n\n\n\n

E: saheed.rashid@bxt-accelyon.com<\/p>\n\n\n\n

T: +44(0)7979-327526<\/p>\n\n\n\n

www.bxt-accelyon.com<\/a><\/p>\n<\/div><\/div><\/div>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":242,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-849","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nASCENDE-RT Study - BXTA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bxta.com\/es\/patient-information\/ascende-rt-study\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASCENDE-RT Study - BXTA\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bxta.com\/es\/patient-information\/ascende-rt-study\/\" \/>\n<meta property=\"og:site_name\" content=\"BXTA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bxtainternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-20T13:30:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BXTA_\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/\",\"url\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/\",\"name\":\"ASCENDE-RT Study - BXTA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bxta-staging.website\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-20-at-14.20.14.png\",\"datePublished\":\"2020-06-20T13:20:42+00:00\",\"dateModified\":\"2020-06-20T13:30:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bxta-staging.website\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-20-at-14.20.14.png\",\"contentUrl\":\"https:\\\/\\\/bxta-staging.website\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-20-at-14.20.14.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bxta.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Information\",\"item\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ASCENDE-RT Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"name\":\"BXTA\",\"description\":\"Let\u2019s tackle Prostate Cancer together | BXTA\",\"publisher\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bxta.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\",\"name\":\"BXTA\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"contentUrl\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"width\":600,\"height\":373,\"caption\":\"BXTA\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bxtainternational\\\/\",\"https:\\\/\\\/x.com\\\/BXTA_\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bxtaccelyon\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkTU9L10CS5c1eWtGiMZ7gw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASCENDE-RT Study - BXTA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bxta.com\/es\/patient-information\/ascende-rt-study\/","og_locale":"es_ES","og_type":"article","og_title":"ASCENDE-RT Study - BXTA","og_url":"https:\/\/bxta.com\/es\/patient-information\/ascende-rt-study\/","og_site_name":"BXTA","article_publisher":"https:\/\/www.facebook.com\/bxtainternational\/","article_modified_time":"2020-06-20T13:30:20+00:00","og_image":[{"url":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@BXTA_","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/","url":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/","name":"ASCENDE-RT Study - BXTA","isPartOf":{"@id":"https:\/\/bxta.com\/uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#primaryimage"},"image":{"@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#primaryimage"},"thumbnailUrl":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png","datePublished":"2020-06-20T13:20:42+00:00","dateModified":"2020-06-20T13:30:20+00:00","breadcrumb":{"@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bxta.com\/patient-information\/ascende-rt-study\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#primaryimage","url":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png","contentUrl":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png"},{"@type":"BreadcrumbList","@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bxta.com\/"},{"@type":"ListItem","position":2,"name":"Patient Information","item":"https:\/\/bxta.com\/patient-information\/"},{"@type":"ListItem","position":3,"name":"ASCENDE-RT Study"}]},{"@type":"WebSite","@id":"https:\/\/bxta.com\/uk\/#website","url":"https:\/\/bxta.com\/uk\/","name":"BXTA","description":"Hagamos frente juntos al c\u00e1ncer de pr\u00f3stata | BXTA","publisher":{"@id":"https:\/\/bxta.com\/uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bxta.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/bxta.com\/uk\/#organization","name":"BXTA","url":"https:\/\/bxta.com\/uk\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/","url":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","contentUrl":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","width":600,"height":373,"caption":"BXTA"},"image":{"@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bxtainternational\/","https:\/\/x.com\/BXTA_","https:\/\/www.linkedin.com\/company\/bxtaccelyon","https:\/\/www.youtube.com\/channel\/UCkTU9L10CS5c1eWtGiMZ7gw"]}]}},"_links":{"self":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/pages\/849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/comments?post=849"}],"version-history":[{"count":7,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/pages\/849\/revisions"}],"predecessor-version":[{"id":860,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/pages\/849\/revisions\/860"}],"up":[{"embeddable":true,"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/pages\/242"}],"wp:attachment":[{"href":"https:\/\/bxta.com\/es\/wp-json\/wp\/v2\/media?parent=849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}